Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Amazon Natural (AZNT) -- Ignore unavailable to you. Want to Upgrade?

To: Cavalry who wrote (6709)	9/21/1998 1:00:00 AM
From: zonkie	Respond to of 26163

LOL....Here's another supplement company you might like cav....check out the short interest. Another Nevada supplement company and more too!!!!!!!!!!!!! Just think $8.04 earnings next year and selling for $1.25. Sounds too good to be true doesn't it? \|_\|_\|_\|_\|_\|_\|_\|_\|_\|_\|_\|_\|_\|_\| LIFELINE BIOTECH OTC BB: LBTI Fiscal Year End: Dec 31 Shares Outstanding: 6.8 million (approx.) Public Float: 2,646,00 (approx.) Assets: $3,090,572 million (approx.) EPS 1999: (est) $8.04 Revenues: 1999(est): 158 million Price: sep 18, 98 Reno, Nevada mawest.com The Company estimates that by the end of the third year. revenues will be approximately $483M, with approximately $171M in net earnings equating to $25.13 EPS (based upon 6.8 million shares outstanding) These projected revenues depend upon certain capital infusion, FDA approval, insurance and Medicare approval of payment, and physicians acceptance. Potentially, the market size is over $6,000,000,000 annually. (M&A West is retained by the company as investor relations counsel.) exchange2000.com And they just had a 50-1 reverse split so it may be a while till the next one. zonkie.....